comparemela.com

Page 13 - Nari News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inari Medical, Inc (NASDAQ:NARI) Given Average Rating of Moderate Buy by Analysts

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Rating) have been assigned an average rating of “Buy” from the nine analysts that are presently covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have issued a report on the […]

EFG Asset Management North America Corp Trims Stake in Inari Medical, Inc (NASDAQ:NARI)

EFG Asset Management North America Corp. reduced its position in Inari Medical, Inc. (NASDAQ:NARI – Get Rating) by 3.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,418 shares of the company’s stock after selling 820 shares during the quarter. EFG Asset Management […]

Truist Financial Raises Inari Medical (NASDAQ:NARI) Price Target to $70 00

Inari Medical (NASDAQ:NARI – Get Rating) had its price objective increased by Truist Financial from $68.00 to $70.00 in a research report sent to investors on Tuesday morning, The Fly reports. Other equities analysts have also issued research reports about the company. Morgan Stanley decreased their price target on Inari Medical from $95.00 to $83.00 […]

Inari Medical, Inc (NASDAQ:NARI) Director William Hoffman Sells 25,000 Shares

Inari Medical, Inc. (NASDAQ:NARI – Get Rating) Director William Hoffman sold 25,000 shares of the stock in a transaction dated Monday, April 17th. The shares were sold at an average price of $64.67, for a total transaction of $1,616,750.00. Following the completion of the transaction, the director now owns 1,227,540 shares of the company’s stock, […]

Inari Medical, Inc (NASDAQ:NARI) Given Average Recommendation of Moderate Buy by Brokerages

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price objective […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.